Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer.
D000328:Adult; D000368:Aged; D000880:Anthraquinones / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007364:Intercalating Agents / Q000008:administration & dosage*; D008875:Middle Aged; D008942:Mitoxantrone; D009362:Neoplasm Metastasis; D013997:Time Factors
D000880:Anthraquinones; D007364:Intercalating Agents; D003520:Cyclophosphamide; D008942:Mitoxantrone; D005472:Fluorouracil